Market Gems:Stocks w/Strong Earnings and High Tech. Rank Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: debra vogt who wrote (56392)	8/18/1999 2:58:00 PM
From: Connor26	Read Replies (1) of 120523

here is one story Wednesday August 18, 1:33 pm Eastern Time LCA says to meet Q3 estimates, stock down In response to a question about the stock drop, LCA President Tom Wilson told Reuters it did not appear to be of a fundamental nature. But Wilson said an analyst at Dane Rauscher Securities had issued a research report in which he mentioned that the company was ``testing a new operating model in some markets. However, he also maintained his recommendation of the company.' A spokesman for LCA said the model mentioned in the report involves a new method LCA is testing in one market for paying its doctors. Rather than paying the doctors about $900 per procedure, LCA is experimenting with paying $150 per surgery plus a fixed salary. The Dane Rauscher analyst, David Therkelsen, could not be reached immediately for comment. Wilson also said there could be some impact from an initial public offering by competitor NovaMed Eyecare Inc. (Nasdaq:NOVA - news), which was reduced to 4 million shares from 7.1 million and the price cut to $8 a share from the expected $9 to $11 range. On Wednesday, Nova was 1-15/32 higher at 9-15/32 on Nasdaq.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next